<DOC>
	<DOCNO>NCT01571037</DOCNO>
	<brief_summary>Right ventricular ( RV ) failure occur estimate 5-41 % case involve leave ventricular assist device ( LVAD ) implantation show adversely affect peri-operative morbidity mortality . Current therapy improve RV dysfunction pre post-operatively limited . Inhaled milrinone show several small human study safely tolerate provide favorable effect pulmonary hemodynamics . Study Hypothesis : Delivery inhale milrinone , phosphodiesterase III inhibitor , may provide pulmonary artery vasodilation therefore improve RV function patient end stage heart failure receive HeartMate II LVAD bridge cardiac transplantation destination therapy . Specifically , aim : - demonstrate safety inhale milrinone patient cohort - demonstrate efficacy inhale milrinone patient cohort</brief_summary>
	<brief_title>Inhaled Milrinone Use Patients Receiving HeartMate II LVAD : A Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Right</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>1 . For BTT candidate : Must approve candidate heart transplantation accord institutional policy 2 . For DT candidate : Patients New York Heart Association ( NYHA ) class IV symptom fail respond maximal medical therapy include beta blocker angiotensin convert enzyme inhibitor tolerate least 45 60 day , OR dependence continuous inotropic therapy 14 day OR dependence intraaortic balloon pump ( IABP ) 7 day Left ventricular ejection fraction ( LVEF ) &lt; 25 % Patients functional limitation cardiopulmonary stress test peak oxygen consumption ≤ 14 ml/kg/min unless balloon pump inotrope dependent physically unable perform test . Patients deem heart transplant candidate evaluation Must mean PAP &gt; 25 mmHg pulmonary catheter index preoperatively ( within 72 hr ) and/or PVR &gt; 3 Woods unit ( WU ) . Age ≥ 19 year old ( state Nebraska , individual must ≥ 19 year old legally provide consent compare age ≥ 18 state ) Signed informed consent Age &lt; 19 year old Pregnancy current breast feeding Undergoing cardiac transplantation without implantation mechanical assist device Documented medical allergy milrinone Failure meet inclusion criterion LVAD implantation BTT DT indication</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>mechanical circulatory assist device</keyword>
</DOC>